Richmond, CA, United States of America

Xiao-Yong Li


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Inventor Xiao-Yong Li

Introduction

Xiao-Yong Li is a prominent inventor based in Richmond, CA (US). She has made significant contributions to the field of pharmacogenomics and chromatin research. With a total of 3 patents, her work focuses on innovative methods for assessing pharmacological effects and identifying drug targets.

Latest Patents

Xiao-Yong Li's latest patents include groundbreaking methods for screening based on isolating a collection of polynucleotides corresponding to accessible regions of chromatin. These methods assess potential pharmacological effects and/or side effects of agents by analyzing their impact on the distribution and properties of accessible regions in cellular chromatin. Additionally, her work involves the identification of drug targets through the reconstruction of signal transduction pathways based on sequences of accessible regions. This innovative approach allows for the selection of therapeutic genes and the determination of regulatory DNA sequences that control gene expression in specific cells.

Career Highlights

Xiao-Yong Li is currently associated with Sangamo Biosciences, Inc., where she continues to advance her research. Her career is marked by a commitment to understanding the complexities of gene regulation and drug interactions.

Collaborations

Some of her notable coworkers include Alan P. Wolffe and Fyodor Urnov, who have collaborated with her on various research projects.

Conclusion

Xiao-Yong Li's contributions to the field of pharmacogenomics and chromatin research highlight her innovative spirit and dedication to advancing medical science. Her patents reflect a deep understanding of gene regulation and its implications for drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…